Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors

Inclusion Criteria: * Patients with an advanced solid tumor which has progressed despite standard therapy, or for which no standard therapy exists * World Health Organization (WHO) performance status ≤ 2 * Patient must meet protocol-specified laboratory values Exclusion Criteria: * Patients with brain cancer * Patients who have concurrent severe and/or uncontrolled medical conditions which could compromise participation in the study * Patients who have not recovered from previous anti-cancer therapies * Female patients who are pregnant, breast feeding, or not willing to use an effective method of birth control Other protocol-defined inclusion/exclusion criteria may apply